Obesity is a major risk factor for cardiovascular disease, the leading cause of death in people with common arthritides such as osteoarthritis (OA), gout, rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis
External resources National Institutes of Health: GLP-1 receptor agonists in obesity management FDA Consumer Update: What you need to know about compounded medicines Making an informed decision about a GLP-1 provider requires comparing cost, transparency, support quality, and the operational realities of how each platform delivers its product
Some formulas, like Collagen NuBest, take a gentler approach with a 1,500 mg daily serving
Foundayo is a room-temperature stable pill, making it highly accessible for patients who travel or lack reliable cold storage